Excerpts from the article.
New research from scientists based at The Westmead Institute in Sydney has drawn a link between the genetic and environmental circumstances of multiple sclerosis.
The project led by immunologist Dr David Booth capitalises on data from a landmark 2013 study that profiled the DNA of 30,000 MS patients worldwide. The study found there are more than 100 genetic risk factors of MS, which is characterised by the scarring of tissue in the central nervous system.
"Previously, it was thought that t-cells orchestrated an attack on the myelin sheath around nerves, causing their destruction," Dr Booth said. "Because we have found out the gene risk types, we now know there are various immune cells involved in this process, and different sub-sets of cells causing MS in different people."
Dr Booth and his team worked backwards to find the cellular source of two of the 110 genes associated with MS, called EOMES and TBX21.
Using blood samples from 50 patients of Westmead Hospital, they were able to identify the immune cell CD56+ as largely responsible for expressing the two risk factor genes. In MS patients, CD56+ cells were found to be inactive or deficient compared with the general population.
"The study has shown that whether these risk factor genes are turned on or off in the CD56+ cell, it is related to Vitamin D activation," Dr Booth explained.
Complete article
http://www.smh.com.au/nsw/sydney-mul...21-gqxob4.html
New research from scientists based at The Westmead Institute in Sydney has drawn a link between the genetic and environmental circumstances of multiple sclerosis.
The project led by immunologist Dr David Booth capitalises on data from a landmark 2013 study that profiled the DNA of 30,000 MS patients worldwide. The study found there are more than 100 genetic risk factors of MS, which is characterised by the scarring of tissue in the central nervous system.
"Previously, it was thought that t-cells orchestrated an attack on the myelin sheath around nerves, causing their destruction," Dr Booth said. "Because we have found out the gene risk types, we now know there are various immune cells involved in this process, and different sub-sets of cells causing MS in different people."
Dr Booth and his team worked backwards to find the cellular source of two of the 110 genes associated with MS, called EOMES and TBX21.
Using blood samples from 50 patients of Westmead Hospital, they were able to identify the immune cell CD56+ as largely responsible for expressing the two risk factor genes. In MS patients, CD56+ cells were found to be inactive or deficient compared with the general population.
"The study has shown that whether these risk factor genes are turned on or off in the CD56+ cell, it is related to Vitamin D activation," Dr Booth explained.
Complete article
http://www.smh.com.au/nsw/sydney-mul...21-gqxob4.html
Comment